Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Analyzing follicular fluid can help predict and improve outcomes for women with PCOS undergoing fertility treatments.

Activins and follistatins, part of the TGFβ family, are crucial for hair follicle development and skin health, affecting growth, repair, and the hair cycle.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

PCOS should be reclassified into two types based on hormone levels and symptoms.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

AKN might be a skin marker for metabolic syndrome.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

PCOS is common among Indian women, often with metabolic issues, needing better management strategies.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Argininosuccinic aciduria can cause hair loss.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.